Here, Plastic Surgery Practice sits down with Constance M. Chen, MD, FACS, a New York-based board-certified plastic surgeon and breast reconstruction specialist, to discuss the latest trends in breast implants and whether concerns surrounding breast implant illness are overblown or valid.
The Plastic Surgery Foundation has expanded its PROFILE Registry to allow all U.S. physicians to report suspected or confirmed cases of breast implant-associated squamous cell carcinoma and other cancers found in the capsule surrounding breast implants.
GLP-1 medications are driving revenue growth and altering patient dynamics across aesthetic practices, creating new opportunities and challenges for plastic surgeons in private practice.
An “influencer” surgeon with millions of followers on social media is calling out the medical community over what he views as painful myths about breast implants, New York Post reports.
Read More
Although the risk for breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) has been well-documented, patients considering breast implants continue to be inadequately informed of the propensity for disease development, according to Cancer Therapy Advisor.
Read More
A new study may be a game changer in the debate: Is breast implant illness real? Read more at azfamily.com.
Read More
The U.S. Food and Drug Administration, in a news release, provides an update regarding adverse events reported to the Agency related to breast implants. Read more about it here.
Read More
Debilitating symptoms known as Breast Implant Illness are likely the cause of the rise in breast implant removal surgeries, but the medical community is divided on whether the condition is real, and unsure who’s at risk, Women’s Health reports.
Read More